Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 CI 41 cells

Molecular Carcinogenesis

Volumn 46, Issue 6, 2007, Pages 436-445

  Ichimatsu, Daisuke ^a   Nomura, Masaaki ^b   Nakamura, Seiji ^a   Moritani, Shuzo ^c   Yokogawa, Koichi ^a   Kobayashi, Shinjiro ^b   Nishioka, Tatsuo ^b   Miyamoto, Ken Ichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c FUKUI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

AP 1; Cell transformation; Flavonoids; PI3K; Signal transduction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; APIGENIN; CENTAUREIDIN; CHALCONE; CHROMONE DERIVATIVE; CHRYSIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EPIGALLOCATECHIN GALLATE; FISETIN; FLAVONE; FLAVONOID; GALANGIN; HESPERETIN; HESPERIDIN; KAEMPFEROL; LUTEOLIN; MYRICETIN; NARINGENIN; PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE; QUERCETIN; RETINOIC ACID; THEAFLAVIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CELL TRANSFORMATION; CHEMICAL BINDING; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; EPIDERMAL GROWTH FACTOR; FLAVONOIDS; MICE; MODELS, CHEMICAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTOR AP-1;

EID: 34250191841     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20292     Document Type: Article

References (33)

1. Crozier A, Burns J, Aziz AA, et al. Antioxidant flavonols from fruits, vegetables and beverages: Measurements and bioavailability. Biol Res 2000;33:79-88.
2. Kanadaswami C, Lee LT, Lee PP, et al. In Vivo 2005;19:895-909.
3. Volate SR, Davenport DM, Muga SJ, Wargovich MJ. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 2005;26:1450-1456.
4. Hou DX, Kai K, Li JJ, et al. Anthocyanidins inhibit activator protein 1 activity and cell transformation: Structure-activity relationship and molecular mechanisms. Carcinogenesis 2004;25:29-36.
5. Rice-Evans C. Flavonoid antioxidants. Curr Med Chem 2001;8:797-807.
6. Masella R, Di Benedetto R, Vari R, Filesi C, Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 2005;16:577-586.
7. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: Antioxidants or signalling molecules? Free Radic Biol Med 2004;36:838-849.
8. Spencer JP, Schroeter H, Kuhnle G, et al. Epicatechin and its in vivo metabolite, 3′-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochem J 2001;354:493-500.
9. Lambert JD, Hong J, Yang GY, Liao J, Yang CS. Inhibition of carcinogenesis by polyphenols: Evidence from laboratory investigations. Am J Clin Nutr 2005;81:284S-291S.
10. Agullo G, Gamet-Payrastre L, Manenti S, et al. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997;53:1649-1657.
11. Lee LT, Huang YT, Hwang JJ, et al. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res 2002;22:1615-1627.
12. Huang YT, Hwang JJ, Lee PP, et al. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 1999;128:999-1010.
13. Ferriola PC, Cody V, Middleton E, Jr. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 1989;38:1617-1624.
14. Matter WF, Brown RF, Vlahos CJ. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun 1992;186:624-631.
15. Huang C, Schmid PC, Ma WY, Schmid HH, Dong Z. Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation. J Biol Chem 1997;272:4187-4194.
16. Colburn NH, Former BF, Nelson KA, Yuspa SH. Tumour promoter induces anchorage independence irreversibly. Nature 1979;281:589-591.
17. Sun Y, Nakamura K, Hegamyer G, Dong Z, Colburn NH. No point mutation of Ha-ras or p53 genes expressed in preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Mol Carcinog 1993;8:49-57.
18. Colburn NH, Wendel E, Srinivas L. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: Use of promoter-resistant variants for mechanism studies. J Cell Biochem 1982;18:261-270.
19. Dong Z, Nomura M, Huang C, Ma WY. Effects of tea polyphenols on the signal transduction pathways. Adv Exp Med Biol 2001;492:55-67.
20. Bode AM, Dong Z. Cancer prevention by food factors through targeting signal transduction pathways. Nutrition 2004;20:89-94.
21. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA 1994;91:609-613.
22. Bernstein LR, Colburn NH. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 1989;244:566-569.
23. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-157.
24. Watts RG, Huang C, Young MR, et al. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene 1998;17:3493-3498.
25. Eriksson M, Leppa S. Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of P19 embryonal carcinoma cells. J Biol Chem 2002;277:15992-16001.
26. Dong Z, Ma W, Huang C, Yang CS. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 1997;57:4414-4419.
27. Nomura M, He ZW, Koyama I, Ma WY, Miyamoto K-I, Dong Z. Involvement of Akt/mTOR pathway on EGF-induced cell transformation. Mol Carcinog 2003;38:25-32.
28. Krasilnikov MA. Phosphatidylinositol-3 kinase dependent pathways: The role in control of cell growth, survival, and malignant transformation. Biochemistry (Mosc) 2000;65:59-67.
29. Stambolic V, Mak TW, Woodgett JR. Modulation of cellular apoptotic potential: Contributions to oncogenesis. Oncogene 1999;18:6094-6103.
30. Brazil DP, Yang ZZ, Hemmings BA. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 2004;29:233-242.
31. Nomura M, Ma WY, Huang C, et al. Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea. Mol Carcinog 2000;28:148-155.
32. Nomura M, Kaji A, He Z, et al. Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 2001;276:46624-46631.
33. Nomura M, Ma WY, Chen N, Bode AM, Dong Z. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. Carcinogenesis 2000;21:1885-1890.